Predictors of the risk of falls among elderly with chronic atrial fibrillation

Clinics

Volumn 67, Issue 4, 2012, Pages 305-311

  dos Santos, Angela Cristina Silva ^a   Nobre, Moacyr Roberto Cucê ^a   Nussbacher, Amit ^a   Rodrigues, Giselle Helena de Paula ^a   Gebara, Otavio Celso Eluf ^a   Azul, João Batista Carvalho Serro ^a   Wajngarten, Mauricio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elderly atrial fibrillation; Falls; Questionnaires; Risk assessment

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; FALLING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICS;

ACCIDENTAL FALLS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84860129318     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(04)02     Document Type: Article

References (47)

1. Maurer MS, Bloomfield DM. Atrial fibrillation and falls in the elderly. Clin Geriatr Med. 2002;18(2):323-37. http://dx.doi.org/10.1016/S0749-0690(02)00013-7.
2. Ott A, Breteler M, Bruyne M, Van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population based study: The Rotterdam Study. Stroke. 1997;28(2):316-21. http://dx.doi.org/10.1161/01.STR.28.2.316.
3. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, et al. Effect of intensity of oral anticoagulantion on stroke severity and mortality in atrial fibrilation. N Engl J Med. 2003;349(11):1019-26 http://dx.doi.org/10.1056/NEJMoa022913.
4. European Heart Rhythm Association Heart Rhythm Society, Fuster, V, Rydén, LE, Cannom, DS, Crijns, HJ, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With. Atrial Fibrillation). J Am Coll Cardiol. 2006 Aug [cited 2011 Aug 31] 15;48(4):854-906. Erratum in: J Am Coll Cardiol. 2007;50(6):562.
5. Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, Rich MW. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med. 2005;118(6):612-7 http://dx.doi.org/10.1016/j.amjmed.2005.02.022.
6. Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med. 1999;159(7):677-85 http://dx.doi.org/10.1001/archinte.159.7.677.
7. Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G, et al. Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation. Circulation. 2011;124(7):824-9. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.007864.
8. The National Institute for Clinical Excellence (NICE). Clinical practice guideline for the assessment and prevention of falls in older people [cited Aug 31]. London: Royal College of Nursing (UK); Nov 2004. Available from http://www.ncbi.nlm.nih.gov/books/NBK55851/pdf/TOC.pdf
9. ProFaNE, School of Nursing, Midwifery and Social, Coupland III, University of Manchester Oxford Road, Manchester M139PL [cited Aug 31]. Great Britain. Available from: www.profane.eu.org.
10. Gerdhem P, Ringsberg KA, Akesson K, Obrant KJ. Clinical history and biology age predicted falls better than objective functional tests. J Clin Epidemiol. 2005;58(3):226-32. http://dx.doi.org/10.1016/j.jclinepi.2004.06.013.
11. Tinetti ME. Preventing Falls in Elderly Persons. N England J Med. 2003;348(1):42-4 http://dx.doi.org/10.1056/NEJMcp020719
12. World Health Organization (WHO). Obesity Preventing and Management Global Epidemic. Report of WHO Consultation on Obesity. Geneva: Who; 1997.
13. Blay S, Ramos LR, Mari J. Validity of a Brazilian version of the older Americans resources and services (OARS) mental health screening questionnaire. J Am Geriatr Soc. 1988;36(8):687-92.
14. Perracini MR, Ramos LR. Fatores associados a quedas em uma coorte de idosos residentes na comunidade. Brazilian Multidimensional Functional Assessment Questionnarire (BOMFAQ) verSão brasileira do Multidimensional Functional Assessment Questionnaire. Rev Saúde Pública. 2002;36(6):709-16.
15. Crum RM, Anthony JC, Basset SS, Folstein MF. Population-based norms for Mini-Mental State Examination by age and educational level. JAMA. 1993;269(18):2420-1.
16. Brucki S, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugestö es para o uso do Mini-Mental do estado mental no Brasil. Arq Neuropsiquiatr 2003;61(3-B):777-81.
17. Spitzer RL, Williams JB, Kroenke K, Linzer M, de Gruy III FV, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(14):1749-5 http://dx.doi.org/10.1001/jama.1994.03520220043029.
18. Fraguas R Jr, Henriques SG Jr, De Lucia MS, Iosifescu DV, Schwartz FH, Menezes PR, et al. The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord. 2006;91(1):11-7 http://dx.doi.org/10.1016/j.jad.2005.12.003.
19. Ferreira, MHF, Dalgalarrondo, P. Prevalência de Transtornos Depressivos em hospital geral e validação do guia clínico Prime MD. In: XII Congresso Interno de Iniciação Científica da UNICAMP, 2004. [citado 2011 Set 01]. Disponível em: http://www.prp.unicamp.br/pibic/congressos/xiicongresso/cdrom/pdfN/598.pdf.
20. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137-45. http://dx.doi.org/10.1002/art.1780230202.
21. Nondahl DM, Cruickshanks KJ, Wiley TL, Tweed TS, Klein R, Klein BE. Accuracy of self-reported hearing loss. Audiology. 1998;35(5):295-301. http://dx.doi.org/10.3109/00206099809072983.
22. Lehman, LF Orsini, MBP, Fuzikawa, PL, Lima, RC, Gonçalves, SD. Avaliação, Neurológica Simplificada. Belo Horizonte. ALM International, 1997. 104p. CDU 616-002.73. Arquivo online. www.saude.pr.gov.br/arquivos/File/hanseniase/public/ans.pdf.
23. Donders FC. Beiträge zur pathologischen Anatomie des Auges. Graefes Arch Clin Exp Ophthalmo. 1855;1(1):106-18.
24. Berg K, Wood-Dauphinee S, Williams JI. The Balance scale: Reliability assessment for elderly residents and patients with an acute stroke. Scand J Rehab Med. 1995;7(1):27-36.
25. Miyamoto ST, Lombardi Jr I, Berg Ko, Ramos LR, Natour J. Brasilian version of the Berg balance scale. Braz J Med Biol Res. 2004;37(9):1411-21 http://dx.doi.org/10.1590/S0100-879X2004000900017.
26. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34(2):114-26.
27. Gomes GC. Tradução, adaptação cultural e exame das propriedades de medida da escala "Performance Oriented Mobility Assessment" POMA para amostragem de idosos brasileiros institucionalizados (dissertação). Campinas: Universidade Estadual de Campinas; 2003.
28. Podsiadlo D, Richard S. The Timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-8.
29. a ed. New York: Duxbury Press; 1994.
30. Andrade S, Santos SCM, Serro-Azul JB. Fibrilação Atrial. In: Wajngarten M. Cardiogeriatria. São Paulo: Roca; 2004. p. 132-6.
31. Hill K, Schwarz J. Assessment and Management of falls in older people. Intern Med J. 2004;34(9-10):557-64. http://dx.doi.org/10.1111/j.1445-5994.2004.00668.x.
32. Feder G, Cryer C, Donovan S, Carter Y. Guidelines for the prevention of falls in people over 65. BMJ. 2000;321(7267):1007-11 http://dx.doi.org/10.1136/bmj.321.7267.1007.
33. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall? JAMA. 2007;297(1):77-86. http://dx.doi.org/10.1001/jama.297.1.77.
34. Brotman DJ, Walker E, Laure MS, O'Brien RG. In search of fewer independent risk factors. Arch Intern Med. 2005;165(2):138-45 http://dx.doi.org/10.1001/archinte.165.2.138.
35. Feinberg WM, Blackshear A. Kronmal R, Hart RG. Prevalence, age, distribution, and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155(5):469-73 http://dx.doi.org/10.1001/archinte.1995.00430050045005.
36. Masud T, Morris RO. Epidemiology of falls. Age Ageing. 2001;30(Suppl 4):S3-7 http://dx.doi.org/10.1093/ageing/30.suppl_4.3.
37. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ. 2003;327(7417):712-7 http://dx.doi.org/10.1136/bmj.327.7417.712.
38. Shumwaycook A, Brauer S, Woollacott M. Predicting the probability for falls in Community-dwelling older adults using the timed up & go test. Phys Ther. 2000;80(9):896-903.
39. Cummings SR, Nevitt MC, Kidd SK. Forgetting falls. The limited accuracy of recall of falls in the elderly. J AM Geriatr Soc. 1988;36(7):613-6
40. Maintenance of sinus rhythm in patient with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. AFFIRM First Antiarrhythmic Drug Substudy Investigators. J Am Coll Cardiol. 2003;42(1):20-9.
41. Greene HL, Graham EL, Werner JA, Sears GK, Gross BW, Gorham JP, et al. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol. 1983;2(6):1114-28 http://dx.doi.org/10.1016/S0735-1097(83)80338-6.
42. Charness ME, Morady F, Scheinman MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology. 1984;34(5):669-7.
43. Palakurthy PR, Iyer V, Meckler RJ. Unusual neurotoxicity associated with amiodarone therapy. Arch Intern Med. 1987;147(5):881-4 http://dx.doi.org/10.1001/archinte.1987.00370050077013.
44. Ahmed S, Rienstra M, Crijns HJGM, Links TP, Wiesfeld ACP, Hillege HL, et al. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. JAMA. 2008;300(15):1784-92 http://dx.doi.org/10.1001/jama.300.15.1784.
45. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997;349(9053):675-82.
46. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, et al. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349(9053):667-74 http://dx.doi.org/10.1016/S0140-6736(96)09145-3.
47. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30(3):791-8 http://dx.doi.org/10.1016/S0735-1097(97)00220-9.